Advertisement
Veracyte, Inc.

Veracyte, Inc. (VCYT) Stock Overview

Explore Veracyte, Inc.โ€™s financial performance, market position, analyst ratings, and future outlook.

VCYTโ—NASDAQ
HealthcareBiotechnology
$46.70
$0.58(1.22%)
U.S. Market is Open ยท 12:35
Advertisement

Veracyte, Inc. (VCYT)

Meyka AI Score

Z

Key Financials

Market Cap3.9B
P/E Ratio43.53
EPS (TTM)$1.08
ROE0.07%
Fundamental Analysis

AI Price Forecasts

1 MonthN/A
3 MonthsN/A
1 Year TargetN/A

VCYT Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Veracyte, Inc. (VCYT) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of F, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 63.14, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of N/A.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 43.53 and a market capitalization of 3.9B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-2.17%
5-Day Change
-2.57%
1-Month Change
19.17%
3-Month Change
46.95%
6-Month Change
11.17%
Year-to-Date (YTD) Change
14.42%
1-Year Change
72.78%
3-Year Change
80.007%
5-Year Change
31.29%
All-Time (Max) Change
263.55%

Contact Information

650 243 6300
6000 Shoreline Court, South San Francisco, CA, 94080

Company Facts

824 Employees
IPO DateOct 30, 2013
CountryUS
Actively Trading

Frequently Asked Questions